Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting {beta}2-agonists: a systematic review and network meta-analysis
Conclusion:
All LAMA/LABA FDCs were found to have similar efficacy and safety. Definitive assessment of the relative efficacy of different treatments can only be performed through direct comparison in head-to-head RCTs. In the absence of such data, this indirect comparison may be of value in clinical and health economic decision-making.
Source: Therapeutic Advances in Respiratory Disease - Category: Respiratory Medicine Authors: Schlueter, M., Gonzalez-Rojas, N., Baldwin, M., Groenke, L., Voss, F., Reason, T. Tags: Original Research Source Type: research
More News: Chronic Obstructive Pulmonary | Corticosteroid Therapy | Health | Respiratory Medicine | Spiriva | Study | Tiotropium